@article{44efdb7060284c5faca0903e8ee33249,
title = "Seizure forecasting: Bifurcations in the long and winding road",
abstract = "To date, the unpredictability of seizures remains a source of suffering for people with epilepsy, motivating decades of research into methods to forecast seizures. Originally, only few scientists and neurologists ventured into this niche endeavor, which, given the difficulty of the task, soon turned into a long and winding road. Over the past decade, however, our narrow field has seen a major acceleration, with trials of chronic electroencephalographic devices and the subsequent discovery of cyclical patterns in the occurrence of seizures. Now, a burgeoning science of seizure timing is emerging, which in turn informs best forecasting strategies for upcoming clinical trials. Although the finish line might be in view, many challenges remain to make seizure forecasting a reality. This review covers the most recent scientific, technical, and medical developments, discusses methodology in detail, and sets a number of goals for future studies.",
keywords = "chronic EEG, circadian, multidien, seizure cycles, seizure forecasting, wearable devices",
author = "Baud, {Maxime O.} and Timoth{\'e}e Proix and Gregg, {Nicholas M.} and Brinkmann, {Benjamin H.} and Nurse, {Ewan S.} and Cook, {Mark J.} and Karoly, {Philippa J.}",
note = "Funding Information: M.O.B. reports personal fees and grants from Wyss Center for Bio‐ and Neuro‐engineering outside the submitted work. M.O.B. has a pending patent under the Patent Cooperation Treaty (#62665486). M.O.B. is a shareholder of Epios, a medical device company based in Geneva, Switzerland. E.S.N., P.K., and M.C. report personal fees and financial interest in Seer Medical, a medical technology company based in Melbourne, Australia. N.M.G. is an investigator for the Medtronic Deep Brain Stimulation Therapy for Epilepsy Post‐Approval Study. B.H.B. reports licensed intellectual property to Cadence Neuroscience, and a consulting agreement with Otsuka Pharmaceuticals. B.H.B. has research support from the National Institutes of Health and Seer Medical. E.S.N. and B.H.B. are supported by the Epilepsy Foundation of America's “My Seizure Gauge” grant. T.P. has no conflict of interest to disclose. We confirm that we have read the Journal's position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. Publisher Copyright: {\textcopyright} 2022 International League Against Epilepsy.",
year = "2022",
doi = "10.1111/epi.17311",
language = "English (US)",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
}